Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Klaudia Kosowska-Shick"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 58:6251-6254
Oritavancin exhibited in vitro activity against 169 strains of vancomycin-susceptible, methicillin-resistant Staphylococcus aureus (MRSA) with MICs ranging from 0.03 to 1 μg/ml and against vancomycin-intermediate MRSA (VISA; n = 29), heterogeneous v
Autor:
Athanassios Tsakris, Ronald N. Jones, Rodrigo E. Mendes, Pamela McGhee, Klaudia Kosowska-Shick, Helio S. Sader, Donald Biek, Peter C. Appelbaum
Publikováno v:
Journal of Antimicrobial Chemotherapy. 67:1321-1324
Objectives To characterize the mechanisms responsible for elevated MICs of ceftaroline for methicillin-resistant Staphylococcus aureus (MRSA). Methods During the 2008 Assessing Worldwide Antimicrobial Resistance Evaluation ('AWARE') surveillance prog
Autor:
Sandrine Lemaire, Klaudia Kosowska-Shick, Paul M. Tulkens, Françoise Van Bambeke, Youri Glupczynski, Peter C. Appelbaum
Publikováno v:
Journal of Antimicrobial Chemotherapy. 66:596-607
BACKGROUND: Co-trimoxazole, clindamycin and linezolid are used to treat community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, but little is known about intracellular activity. Moxifloxacin is active against intracellula
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:673-677
We tested the propensity of three quinolones to select for resistant Streptococcus pneumoniae mutants by determining the mutant prevention concentration (MPC) against 100 clinical strains, some of which harbored mutations in type II topoisomerases. C
Autor:
Peter C. Appelbaum, Linda Beachel, Klaudia Kosowska-Shick, Glenn A. Pankuch, Pamela McGhee, Catherine Clark, Bonifacio Dewasse
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:4217-4224
This study used CLSI broth microdilution to test the activity of telavancin and comparator antimicrobial agents against 67 methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates. Twenty-six vancomycin-intermediate S. aureus (VISA) s
Autor:
Linda Beachel, Catherine Clark, Pamela McGhee, Peter C. Appelbaum, Bonifacio Dewasse, Klaudia Kosowska-Shick
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:3118-3121
Multistep and single-step resistance selection studies were performed with razupenem, linezolid, and vancomycin against 10 methicillin (meticillin)-resistant and -susceptible Staphylococcus aureus strains. After 20 daily subcultures, razupenem yielde
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:2239-2247
For 297 penicillin-susceptible, -intermediate, and -resistant pneumococcal strains, the sulopenem MIC 50 s were 0.008, 0.06, and 0.25, respectively, and the sulopenem MIC 90 s were 0.016, 0.25, and 0.5 μg/ml, respectively. The MIC 50 s of amoxicilli
Autor:
Toyojiro Matsuishi, Hidenobu Hidaka, Peter C. Appelbaum, Kenji Gotoh, Masaaki Ikenaga, Naoki Tsumura, Kensuke Nagai, Klaudia Kosowska-Shick, Hiroyasu Koga, Kenji Masunaga
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 62:16-22
MICs of penicillin G, erythromycin, clarithromycin, clindamycin, azithromycin, and telithromycin were tested for 189 clinical isolates collected during 2002 to 2005 from children in southwestern Japan. Serotyping and polymerase chain reaction for pre
Autor:
Aileen Rubio, Lois M. Ednie, Cynthia Whitener, Tatiana Bogdanovich, Kathleen G. Julian, Laura M. Koeth, Martin Roos, Harald Labischinski, Klaudia Kosowska-Shick, Peter C. Appelbaum, Leslie J. Parent
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:3445-3448
We analyzed the emergence of daptomycin nonsusceptibility in a patient with persistent vancomycin-intermediate Staphylococcus aureus (VISA) bacteremia. The daptomycin-nonsusceptible VISA's cell wall demonstrated a reduction in muramic acid O -acetyla
Autor:
Bonifacio Dewasse, Pamela McGhee, Peter C. Appelbaum, Gengrong Lin, Klaudia Kosowska-Shick, Bülent Bozdogan, Dong-Rack Choi, Glenn A. Pankuch, Jei Man Ryu, Kim L. Credito
Publikováno v:
Antimicrobial Agents and Chemotherapy. 50:2064-2071
DW-224a is a new broad-spectrum quinolone with excellent antipneumococcal activity. Agar dilution MIC was used to test the activity of DW-224a compared to those of penicillin, ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin, gemifloxacin, amo